Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: ZXP96ZI2RA

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Programmed cell death 1 ligand 1 binding agent PubMed Other Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 2 D008545 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297563
FDA SRS ZXP96ZI2RA